论文部分内容阅读
目的观察在静脉溶栓治疗的基础上 ,配合中药治疗急性心肌梗塞 ( AMI)的疗效。方法 2 8例 AMI患者随机分两组 ,均按西医常规治疗和溶栓治疗 ,治疗组另加中药治疗 (参麦注射液和灯盏花注射液 ) ,观察临床疗效及心肌酶降至正常时间、血液流变学指标。结果治疗组显效 9例 ,有效 5例 ,无效 1例 ,总有效率 93.3% ;对照组显效 7例 ,有效4例 ,无效 1例 ,死亡 1例 ,总有效率 84.6 %。两组疗效比较差异无显著性意义 ( P>0 .0 5 ) ,但血清心肌酶降至正常平均时间治疗组明显短于对照组 ( P<0 .0 1) ,血液流变学指标对比显示治疗组治疗前后差异有显著性意义 ( P<0 .0 0 1)。结论提示中药对心肌损伤修复、降低血液粘稠度、改善微循环有益 ,可以改善 AMI的预后
Objective To observe the curative effect of intravenous thrombolysis combined with traditional Chinese medicine in the treatment of acute myocardial infarction (AMI). Methods Twenty-eight patients with AMI were randomly divided into two groups. All patients were treated with conventional western medicine and thrombolytic therapy. The treatment group was treated with traditional Chinese medicine (Shenmai injection and Erigeron Injection), and the clinical efficacy and myocardial enzymes were reduced to normal, Hemorheology index. Results In the treatment group, 9 cases were markedly effective, 5 cases were effective, 1 case was ineffective, and the total effective rate was 93.3%. In the control group, 7 cases were markedly effective, 4 cases effective, 1 ineffective and 1 case dead. The total effective rate was 84.6%. There was no significant difference between the two groups (P> 0.05), but serum myocardial enzymes decreased to normal average time in the treatment group was significantly shorter than the control group (P <0.01), blood rheology indicators showed The difference between the treatment group before and after treatment was significant (P <0.01). The results suggest that Chinese medicine can improve the prognosis of myocardial injury, repair myocardial damage, reduce blood viscosity and improve microcirculation